# | Name | Compound Key | Action Type | Relation | Activity Value | Units | Assay ID | Assay Description | Comment | Assay | Assay Organism | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
1. | ALA4859660 | I-9 | INH | = | 0 | % | ALA4804663 | % | Homo sapiens | |||
2. | ALA4868141 | I-65 | INH | = | 0 | % | ALA4804663 | % | Homo sapiens | |||
3. | ALA4855730 | I-51 | INH | = | 0 | % | ALA4804663 | % | Homo sapiens | |||
4. | ALA4867931 | I-50 | INH | = | 0 | % | ALA4804663 | % | Homo sapiens | |||
5. | ALA4860979 | I-28 | INH | = | 0 | % | ALA4804663 | % | Homo sapiens | |||
6. | ALA4855542 | I-13 | INH | = | 0 | % | ALA4804663 | % | Homo sapiens | |||
7. | ALA4859660 | I-9 | % inhibition | = | -5 | uM | ALA4804481 | Data is reported as I50 but values are consistent with % inhibition, changed for ChEMBL32 at suggestion of BZ | uM | Homo sapiens | ||
8. | ALA4868141 | I-65 | % inhibition | = | -55.9 | uM | ALA4804481 | Data is reported as I50 but values are consistent with % inhibition, changed for ChEMBL32 at suggestion of BZ | uM | Homo sapiens | ||
9. | ALA4855730 | I-51 | % inhibition | = | -47.4 | uM | ALA4804481 | Data is reported as I50 but values are consistent with % inhibition, changed for ChEMBL32 at suggestion of BZ | uM | Homo sapiens | ||
10. | ALA4867931 | I-50 | % inhibition | = | -4.6 | uM | ALA4804481 | Data is reported as I50 but values are consistent with % inhibition, changed for ChEMBL32 at suggestion of BZ | uM | Homo sapiens | ||
11. | ALA4860979 | I-28 | % inhibition | = | 10.1 | uM | ALA4804481 | Data is reported as I50 but values are consistent with % inhibition, changed for ChEMBL32 at suggestion of BZ | uM | Homo sapiens | ||
12. | ALA4855542 | I-13 | % inhibition | = | -6.4 | uM | ALA4804481 | Data is reported as I50 but values are consistent with % inhibition, changed for ChEMBL32 at suggestion of BZ | uM | Homo sapiens | ||
13. | ALA4084955 | 14 | INH | = | -7.7 | % | ALA4034475 | % | Homo sapiens | |||
14. | R406 (free base) | 5, R-406 | Kd apparent | > | 30000 | nM | ALA3991917 | Inactive | nM | Homo sapiens | ||
15. | BEZ235 | SID124898663 | Kd apparent | > | 30000 | nM | ALA3991917 | Inactive | nM | Homo sapiens | ||
16. | Fedratinib (SAR302503, TG101348) | 2, TG101348 | Kd apparent | > | 30000 | nM | ALA3991917 | Inactive | nM | Homo sapiens | ||
17. | Afatinib | BIBW-2992 | Kd apparent | > | 30000 | nM | ALA3991917 | Inactive | nM | Homo sapiens | ||
18. | MK-1775 | SID103905025 | Kd apparent | > | 30000 | nM | ALA3991917 | Inactive | nM | Homo sapiens | ||
19. | Alisertib (MLN8237) | 9, MLN-8237 | Kd apparent | > | 30000 | nM | ALA3991917 | Inactive | nM | Homo sapiens | ||
20. | Ponatinib (AP24534) | 20g, AP24534 | Kd apparent | > | 30000 | nM | ALA3991917 | Inactive | nM | Homo sapiens |